{
    "SPADE_UN_13951": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_13951",
            "Peptide Name": "4324(derived from the RNase H domain of HIV-1 RT (20-mes))",
            "Source": "Synthetic construct(derived from HIV-1 Reverse Transcriptase)",
            "Family": "Retroviridae",
            "Gene": "Not found",
            "Sequence": "EQVDKLVSAGIRKVLFLDGI",
            "Sequence Length": 20,
            "UniProt Entry": "No entry found",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Antimicrobial",
                "Antiviral"
            ],
            "Target Organism": "[Ref.15790559]HIV-1:the level of peptide binding to HIV integrase is high.",
            "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry",
            "Cytotoxicity": "No cytotoxicity information or data found in the reference(s) presented in this entry",
            "Binding Target": "Integrase",
            "Linear/Cyclic": "Linear",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Free",
            "Stereochemistry": "L",
            "Structure Description": "Not found",
            "Formula": "C100H170N26O29",
            "Mass": 2200.58,
            "PI": 6.22,
            "Net Charge": 0,
            "Hydrophobicity": 0.48,
            "Half Life": "Mammalian:1 hourYeast:30 minE.coli:>10 hour",
            "Mechanism of action": "Two viral encoded enzymes(reverse transcriptase and integrase) play central roles in the early stages of the replication of retroviruses and retrotransposons.The peptide derived from the RNase H domain of HIV-1 RT inhibits integrase-associated activities (3â€²-end processing and strand transfer) and inhibit virus replication.",
            "Literature": [
                {
                    "Title": "Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase.",
                    "Pubmed ID": "15790559",
                    "Reference": "J Biol Chem. 2005 Jun 10;280(23)21987-96.",
                    "Author": "Oz Gleenberg I, Avidan O, Goldgur Y, Herschhorn A, Hizi A.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=15790559"
                }
            ],
            "Frequent Amino Acids": "LVD",
            "Absent Amino Acids": "CHMNOPTUWY",
            "Basic Residues": 3,
            "Acidic Residues": 3,
            "Hydrophobic Residues": 10,
            "Polar Residues": 9,
            "Positive Residues": 3,
            "Negative Residues": 3,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_01818",
                    "Similarity": 0.6666666666666666,
                    "Sequence": "GLLDGILNANFNAAKSAGTSVLNALSCKLSKTC"
                },
                {
                    "SPADE_ID": "SPADE_UN_22951",
                    "Similarity": 0.5,
                    "Sequence": "FWQRGIRKVR"
                },
                {
                    "SPADE_ID": "SPADE_N_09949",
                    "Similarity": 0.5,
                    "Sequence": "KVLFPVLFP"
                }
            ]
        }
    }
}